€10.7M
The funding from the Disruptive Technology Innovation Fund will support clinical trials for the CanVas-001 cell therapy candidate.
HL
HAON Life Sciences
Developing regenerative cell therapies to treat neonatal brain injuries.
Ireland—Founded 2022
€10.7MTotal raised
Irish biotechnology startup developing cell-based therapies for infant brain injuries.
Categories
Founders
MO
Mark O’Neill
FCA
MH
Moayed Hamza
Co-founder